Cargando…
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment
The current pandemic coronavirus, SARS-CoV-2, is a global health emergency because of its highly contagious nature, the great number of patients requiring intensive care therapy, and the high fatality rate. In the absence of specific antiviral drugs, passive prophylaxis, or a vaccine, the treatment...
Autores principales: | Prete, Marcella, Favoino, Elvira, Catacchio, Giacomo, Racanelli, Vito, Perosa, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247005/ https://www.ncbi.nlm.nih.gov/pubmed/32397684 http://dx.doi.org/10.3390/ijms21093377 |
Ejemplares similares
-
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
por: Prete, Marcella, et al.
Publicado: (2020) -
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading
por: Favoino, Elvira, et al.
Publicado: (2019) -
HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
por: Favoino, Elvira, et al.
Publicado: (2021) -
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis
por: Perosa, Federico, et al.
Publicado: (2013) -
Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis
por: Favoino, Elvira, et al.
Publicado: (2013)